32
Slide 1 Associate Professor, Maternal-Fetal Medicine Departments of Obstetrics & Gynecology and Psychiatry University of Colorado School of Medicine, CO, USA

Associate Professor, Maternal-Fetal Medicine Departments

  • Upload
    others

  • View
    6

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Associate Professor, Maternal-Fetal Medicine Departments

Slide 1

Associate Professor, Maternal-Fetal Medicine

Departments of Obstetrics & Gynecology and Psychiatry

University of Colorado School of Medicine, CO, USA

Page 2: Associate Professor, Maternal-Fetal Medicine Departments

Slide 2

Disclosures

Camille Hoffman No commercial or industry disclosures

Represented the Society for Maternal Fetal Medicine (SMFM) on the Council on Patient Safety in Women’s Health Care on this topic (for free)

Page 3: Associate Professor, Maternal-Fetal Medicine Departments

Slide 3

Objectives

Discuss Postpartum Depression Epidemiology-it’s common!

Review the implementation of traditional screening tools and places where we “miss” it

Consider methods for engaging patients and their families in recognizing signs and symptoms and linking treatment and support

Page 4: Associate Professor, Maternal-Fetal Medicine Departments

Slide 4

Council Participation on the Maternal Mental Health Safety Bundle

Page 5: Associate Professor, Maternal-Fetal Medicine Departments

Slide 5

Why Worry about PPD?

CDC estimates 8-19% of women will experience a depressive episode during or after pregnancy.

www.acog.org/Womens-Health/Depression-and-Postpartum-Depression

Page 6: Associate Professor, Maternal-Fetal Medicine Departments

Slide 6

Poor health care Substance abuse Cognitive delays Behavioral problems

Bodnar et al (2009) J Clinical Psychiatry. Cripe et al (2011). Paediatric Perinatal Epid. Flynn & Chermack (2008) J Studies on Alcohol and Drugs. Forman et al (2007) Dev Psychopathology. Grote et al (2010) Archives General Psych. Sohr-Preston & Scaramella, (2006) Clinical Child and Family Psychology Review. Wisner et al (2009) Am J Psychiatry.

Preterm delivery Low birth weight Preeclampsia

©MCPAP For Moms

Why Worry about PPD? Affects Mom, Child and Family

Untreated maternal depression can have a devastating effect on women, their infants and their families.

Page 7: Associate Professor, Maternal-Fetal Medicine Departments

Slide 7

Why Worry about PPD? In extreme form, depressive psychosis can lead to maternal suicide

and/or infanticide.

Maternal suicide within a year of birth is emerging as a significant cause of maternal mortality, and is probably underreported.

© 2016 by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved. Published by Lippincott Williams & Wilkins, Inc.

Maternal deaths in Colorado from 2004 to 2012 (N=211)

Metz T, Rovner P, Hoffman M, Allshouse A, Beckwith K, Binswanger I, Maternal Deaths From Suicide and Overdose in Colorado, 2004-2012. Obstetrics & Gynecology. 2016; 128(6):1233-1240. DOI: 10.1097/AOG.0000000000001695

Page 8: Associate Professor, Maternal-Fetal Medicine Departments

Slide 8

Ten-year pregnancy-associated mortality rates for deaths by violence and injury compared with the leading obstetric causes in Illinois, 2002-2011.

Koch A, Rosenberg D, Geller S. Higher Risk of Homicide Among Pregnant and Postpartum Females Aged 10-29 Years in Illinois, 2002-2011. Obstetrics & Gynecology. 2016; 128(3):440-446. DOI: 10.1097/AOG.00000000000015590

Maternal Mortality Risk: Homicide, Suicide

Page 9: Associate Professor, Maternal-Fetal Medicine Departments

Slide 9

The perinatal period is ideal for the detection and treatment of perinatal

depression and anxiety.

Regular opportunities to screen and

engage women in treatment.

Front line providers have a pivotal role.

De-stigmatize

Educate

Proactively initiate and welcome

conversation.

So, how do we miss it?......

©MCPAP For Moms

Page 11: Associate Professor, Maternal-Fetal Medicine Departments

Slide 11

Risk Factors for PMADs/PPD

1. Akincigil A et al. Soc Work Health Care, 2010; 2. Rich-Edwards JW et al. J Epidemiol Comm Health, 2006; Howard LM et al. PLoS Med, 2013; 4. Wosu AC et al. Arch Womens Ment Health, 2015; 5. Lefkowitz DS et al. J Clin Psychol Med Setting, 2010

Page 12: Associate Professor, Maternal-Fetal Medicine Departments

Slide 12

Risk Factors for PMADs/PPDSwedish series (n=700,000, 1997-2008)

Silverman ME et al. Depression Anxiety, 2017

Page 13: Associate Professor, Maternal-Fetal Medicine Departments

Slide 13

Current RecommendationsUSPSTF Draft recommendation August 2018

USPSTF Recommendation January 2016

Recommends depression screening for pregnant women

Screening should be done both antepartum and postpartum.

ACOG published Committee Opinion #630 -May 2015

Screen patients at least once during the perinatal period for depression and anxiety symptoms using a standardized, validated tool.

American Academy of Pediatrics guideline -2010

Pediatricians to screen mothers for depressive symptoms

at well child visits at 1, 2 and 4 months.

Recognized maternal depression can impact failure-to-thrive and other pediatric issues.

CDC and WHO

Within 12 months Postpartum

Council on Patient Safety in Women’s Health Care (Feb. 2016)

Recommends Bundle implementation

across settings.

Page 14: Associate Professor, Maternal-Fetal Medicine Departments

Slide 14

When should women be screened for Perinatal Mood and Anxiety Disorders (PMAD)?

Depression & Anxiety

At least once during the perinatal period

Depression

At least once during pregnancy and again postpartum

ACOG CO 630 May 2015; USPSTF JAMA 2016, draft recs 2018

Women found at risk should be referred for counseling

Page 15: Associate Professor, Maternal-Fetal Medicine Departments

Slide 15

Two-thirds of perinatal depression begins before birth

Pregnancy

33%

Postpartum 40%

Before pregnancy

27%

Wisner et al. JAMA Psychiatry 2013

Optimal screening times and intervals not identified.

Screen at least once during perinatal period using standardized, validated tool.

(ACOG, 2015)

Screen mother at 1,2, 4 and 6 mo. well-child visits. (Earls, 2010)

Page 16: Associate Professor, Maternal-Fetal Medicine Departments

Slide 16

ACOG CO #630 – May 2015. Reprinted in Kendig et al, Consensus Bundle on Maternal Mental Health, Obstet Gynecol 2017.

Page 17: Associate Professor, Maternal-Fetal Medicine Departments

Slide 17

• Depression AND Anxiety

• Perinatal Populations Only

• >40 languages

http://linkingcare.org/ScreeningTool/EPDS

http://perinatology.com

Page 18: Associate Professor, Maternal-Fetal Medicine Departments

Slide 18

1

• Positive Screening Instrument

2• Diagnostic Interview

3

• Suicidality & Psychosis• Bipolar Disorder Screen

In an Ideal World…

Page 19: Associate Professor, Maternal-Fetal Medicine Departments

Slide 19

Distinguish Baby Blues & PPD

Baby Blues

• Peaks ~5th day PP

• Resolves within 10-14 days PP w/out treatment

• 50-80% of all new mothers

• Crying, worry/anxiety; feeling sad, moody, irritable, restless; anger or rage; symptoms do not interfere w/newborn care and resolve w/out intervention

Postpartum Depression (PPD)

• During pregnancy or w/in first 4 weeks PP (DSM5)

• Can persist if left untreated

• 8-20% (+) of new mothers in US

• Difficulty bonding; crying; worry/anxiety; doubt in ability to care for baby; feeling sad, moody, irritable, restless; anger or rage; anhedonia; sleep and/or appetite abnormalities; difficulty concentrating, withdrawal

Onset

Duration

Prevalence

Symptoms

Page 20: Associate Professor, Maternal-Fetal Medicine Departments

Slide 20

In the Ob’s or Midwife’s World:

Screen “positive”

Mild symptoms, Does not meet criteria

For clinical depression or anxiety

Moderate SymptomsMeets criteria for mild clinical depression, anxiety, or both

Severe Symptoms Meets criteria for severe clinical

depression, anxiety, or both

All of the above PLUSFacilitate urgent access to counseling

servicesStart on anti-depressant medication if

no history of maniaEarlier follow up in one week

Severe SymptomsWith suicidal or homicidal

features or

symptoms of mania or psychosis

At risk for harm to self, others,

or baby?

Education on worsening symptomsHealthy nutrition, physical activitySleepIntegrative strategiesHelp with family chores, childcareAssess available resources

yes

no

no

no

All of the above PLUSArrange follow up in 2 weeksOffer counseling or medications Ensure safety net: re family supportEmergency plan if symptoms worsen

TREATMENTPRESENTATION

Emergent referral for evaluation andpossible hospital admission

Page 21: Associate Professor, Maternal-Fetal Medicine Departments

Slide 21 ©MCPAP For Moms

Seek psychiatric consultation

1Taken from the Composite International Diagnostic Interview-Based Bipolar Disorder Screening Scale (Kessler, Akiskal, Angst et al., 2006)

Page 22: Associate Professor, Maternal-Fetal Medicine Departments

Slide 22

Manage Suicidal Ideation

Screen patients with depression for

o Suicidal thoughts, how often in past 2 weeks?o Suicidal intent/plan

o What has stopped them so far?

o Availability/lethality of method

Activate emergency referral protocol for women with suicidal/homicidal ideation

o Consultation, transportation, admission

o Maintain open communication among team members

o Post event planning for care coordination and follow-up

Page 23: Associate Professor, Maternal-Fetal Medicine Departments

Slide 23

When to Seek Consultation

Failed response to medication

Persistent psychosocial problems

Complicated psychological problems

Actively suicidal

Discomfort in managing the problem

“Gut feeling”

Page 24: Associate Professor, Maternal-Fetal Medicine Departments

Slide 24

So how are we still missing it?Barriers to Diagnosis & Treatment

Perinatal Care Provider Barriers

Leddy M et al. J Psychosom Obstet Gynecol, 2011

Page 25: Associate Professor, Maternal-Fetal Medicine Departments

Slide 25

When Initiating Treatment…

….Get Everyone on the Same Page

Start treatment, start referral process (for postpartum period and beyond)

Coordinate care between maternity care, mental health, and primary care providers during the prenatal and postpartum period.

Establish a plan for care beyond the postpartum period

Assure release of information forms are in place.

Page 26: Associate Professor, Maternal-Fetal Medicine Departments

Slide 26

Strategies to engage patients and their families in recognizing signs and

symptoms: Talk About It

Normalize Perinatal Mental Health (PMH)

Include education in new patient packets along with

information on other common complications.

Review common symptoms often.

Include family and support system in educational process.

Helping families and support system understand “Red

Flags.”

Listen, Support, Offer help.

Page 27: Associate Professor, Maternal-Fetal Medicine Departments

Slide 27

Links for Patients, Families

• https://www.nichd.nih.gov/ncmhep/MMHM/Pages/index.aspx

• http://www.postpartum.net

• http://www.postpartumprogress.com/the-symptoms-of-postpartum-

depression-anxiety-in-plain-mama-english

• http://store.samhsa.gov/shin/content/SMA14-4878/SMA14-4878.pdf

Page 28: Associate Professor, Maternal-Fetal Medicine Departments

Slide 28

Healthcare Support

• Community Perinatal Mood Disorders Support Group

• Interdisciplinary teams

• Local and state programs

• County health clinics

• www.safehealthcareforeverywoman.org

• www.mcpapformoms.org

• www.colorado.gov/pacific/cdphe/pregnancy-related-depression

• www.nichd.nih.gov/ncmhep/MMHM/Pages/index.aspx

Page 29: Associate Professor, Maternal-Fetal Medicine Departments

Slide 29

Establish Local Standards

Consider:

Documentation of screening at specified intervals

Utilize EMR for reminders

Documentation of screening results

Documentation of plan of care

Documentation of referral and follow up

Appropriate diagnostic code

Page 30: Associate Professor, Maternal-Fetal Medicine Departments

Slide 30

Many Thanks:Maternal Mental Health: Perinatal Depression and Anxiety Patient Safety Bundle Workgroup

Chairs: Susan Kendig, JD, WHNP-BC

John Keats, MD

• Readiness• Emily Miller – Lead

• Susan Kendig

• Katherine Wisner

• Recognition • Tiffany Moore-Simas – Lead

• Ariela Frieder

• Chris Raines

• Response • Camille Hoffman – Lead

• Barbara Hackley

• Pec Indman

• Reporting & Systems Learning • Lisa Kay – Lead

• John Keats

• Kisha Semenuk

• Council Support• Lauren Lemieux

Page 31: Associate Professor, Maternal-Fetal Medicine Departments

Slide 31

Contact Information

M. Camille Hoffman, MD, MSCS, FACOG [email protected]

Page 32: Associate Professor, Maternal-Fetal Medicine Departments

Slide 32

• Antidepressants in pregnancy- are some better than others?

• 3 slides, 6 minutes